Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology

Simple item page
dc.contributor.authorManigold, Tobías
dc.contributor.authorVial, Pablo
dc.date.accessioned2015-01-13T14:25:35Z
dc.date.available2015-01-13T14:25:35Z
dc.date.issued2014
dc.description.abstractIn humans, hantaviruses can cause haemorrhagic fever with renal syndrome (HFRS) or hantavirus cardiopulmonary syndrome (HCPS). Currently it is estimated that 150,000 to 200,000 cases of hantavirus disease occur each year, the majority being reported in Asia. However, human hantavirus infections are increasingly reported in the Americas and Europe. Although many of the underlying pathogenic mechanisms still remain unclear, recent evidence rather argues against a purely immune-mediated pathophysiology of human disease. Despite the high morbidity and case-fatality rates of HFRS and HCPS, respectively, no vaccine or drug is currently proven to be preventive or therapeutic. This review summarises clinical features and current epidemiological findings, as well as concepts regarding the immunology, pathogenesis and intervention strategies of human hantaviral diseases.
dc.identifier.citationSwiss Medical Weekly, Mach 2014, n°144, p. w13937
dc.identifier.urihttp://hdl.handle.net/11447/50
dc.identifier.urihttp://dx.doi.org/10.4414/smw.2014.13937
dc.language.isoen_US
dc.publisherSwiss Society of Internal Medicine, Swiss Society of Infectiology and Swiss Society of Rheumatology
dc.subjectHantavirus
dc.subjectImmunology
dc.subjectPathogenesis
dc.subjectHCPS
dc.subjectHFRS
dc.titleHuman hantavirus infections: epidemiology, clinical features, pathogenesis and immunology
dc.typeArtículo

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Manigold & Vial_Human hantavirus_2014.pdf
Size:
548.15 KB
Format:
Adobe Portable Document Format
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services